ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.430
+0.013 (2.99%)
Nov 4, 2024, 4:00 PM EST - Market closed
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $12.40 million as of November 4, 2024. Its market cap has decreased by -60.39% in one year.
Market Cap
12.40M
Enterprise Value
21.22M
1-Year Change
-60.39%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $12.40M, a decrease of -95.05%. That is a compound annual growth rate of -54.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 11.40M | -73.36% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 12.88M |
| Sensei Biotherapeutics | 12.82M |
| Cosmos Health | 12.82M |
| Autonomix Medical | 12.72M |
| Vivos Therapeutics | 12.54M |
| BiomX | 12.37M |
| STRATA Skin Sciences | 12.26M |
| Evogene | 12.22M |